CONGRESSWOMAN ELISE STEFANIK
On Monday, February 2, 2015, the House will consider H.R. 361, the Medical Preparedness Allowable Use Act, under a suspension of the rules. H.R. 361 was introduced on January 14, 2015 by Rep. Gus Bilirakis (R-FL) and referred to the Committee on Homeland Security.
H.R. 361 is substantively identical to H.R. 1791, the Medical Preparedness Allowable Use Act, legislation that previously passed in the House on February 3, 2014 by a vote of 391-2. (See Roll Call #32)
H.R. 361 amends the Homeland Security Act of 2002 to codify authority under existing grant guidance authorizing the use of Urban Area Security Initiative (UASI) and State Homeland Security Grant Program (SHSGP) funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities. This includes the development and maintenance of an initial pharmaceutical stockpile, including medical kits and diagnostics sufficient to protect first responders and their families, immediate victims, and vulnerable populations from a chemical or biological event.
Through hearings and briefings throughout the 112th and 113th Congress, the Committee on Homeland Security received information from federal, state, and local stakeholders about the importance of medical preparedness. This legislation ensures that UASI and SHSGP funds are available for medical preparedness uses.
According to CBO estimates conducted for identical legislation in the 113th Congress, implementing H.R. 361 would not affect federal expenditures and would have no impact on the federal budget over the next five years.
For questions or further information contact the GOP Conference at 5-5107.